routinely recommend cytoreductive therapy; however, this is another situation in which shared decision-making is vital. Broadly speaking, the lack of consensus regarding the impact of platelet count in ET suggests this is a complex relationship that is
Search Results
Andrew T. Kuykendall and Rami Komrokji
Romy M. van Amelsfoort, Iris Walraven, Jacobien Kieffer, Edwin P.M. Jansen, Annemieke Cats, Nicole C.T. van Grieken, Elma Meershoek-Klein Kranenbarg, Hein Putter, Johanna W. van Sandick, Karolina Sikorska, Cornelis J.H. van de Velde, Neil K. Aaronson, Marcel Verheij, and on behalf of the CRITICS Investigators
predicted survival. These findings provide consistent evidence supporting the potential usefulness of taking baseline HRQoL into account in doctor–patient communication and in shared decision-making about the choice of treatment. We are the first to apply
Peter D. Stetson, Nadine J. McCleary, Travis Osterman, Kavitha Ramchandran, Amye Tevaarwerk, Tracy Wong, Jessica M. Sugalski, Wallace Akerley, Annette Mercurio, Finly J. Zachariah, Jonathan Yamzon, Robert C. Stillman, Peter E. Gabriel, Tricia Heinrichs, Kathleen Kerrigan, Shiven B. Patel, Scott M. Gilbert, and Everett Weiss
, including whether it is used to facilitate shared decision-making between providers and patients. We also did not obtain the technical or operational specifics regarding how those centers that have had the most success with PGHD integration have accomplished
Brady J. McKee, Shawn Regis, Andrea K. Borondy-Kitts, Jeffrey A. Hashim, Robert J. French Jr, Christoph Wald, and Andrea B. McKee
conduct the CTLS shared decision-making visit. 7 All CTLS examinations were performed on ≥64-row multidetector CT scanners at 100 kV and 30 to 100 mA depending on availability of iterative reconstruction software. Image interpretation was performed by
Jordan M. Cloyd, Chengli Shen, Heena Santry, John Bridges, Mary Dillhoff, Aslam Ejaz, Timothy M. Pawlik, and Allan Tsung
-making occurs for patients with resectable PDAC and whether specific barriers to the use of NT exist. Further data on patient and physician preferences and the patient experience during NT may highlight opportunities to improve shared decision-making and
Presenters: Benjamin O. Anderson and Janice A. Lyons
, and whose RT can be limited to the breast and not include the nodes, Dr. Lyons added. She emphasized that shared decision-making is critical in situations such as this. “The patient may want to accept a higher risk of locoregional recurrence versus
Aysegul A. Sahin, Timothy D. Gilligan, and Jimmy J. Caudell
undergo surveillance unless there is compelling reason not to. However, patients with larger tumors may prefer radiation or chemotherapy if they know they have a higher risk of relapse. So tumor size can facilitate shared decision-making.” The other area
provider Promote policies and reimbursement mechanisms that support interoperability and encourage the aggregation of patient data that will promote shared decision-making and increase understanding between patients, providers, and payers Maintain and
has worked elsewhere, and making sure these discussions include input from patient advocates. Visit NCCN.org to learn more about the tools NCCN provides to encourage prevention and enable shared decision-making between patients and providers
Jessica K. DeMartino and Jonathan K. Larsen
, monitoring, and management for patients and survivors. 17 The use of PROs in everyday clinical practice can promote better communication and shared decision-making by patients and providers, and help distinguish physical, emotional, and social issues that